Another study shows that patients with symptomatic COVID-19 have diminished serum sphingosine levels compared to asymptomatic counterparts, who also exhibit elevated acid ceramidase (AC), an enzyme that converts ceramide in sphingosine (38). The gene discussed is ASAH1; the disease is COVID-19.